In this Redefining Lung Cancer Together podcast episode, Emilie Prazakova – Senior Patient Partnership Leader at Roche – sits down with Lorraine Tyler, an advocate and woman living with lung cancer, and Mark Brooke, CEO of Lung Foundation Australia, to discuss the critical importance of biomarker testing in lung cancer.
Lorraine and Mark have a touching discussion, sharing personal perspectives about the positive impact that early biomarker testing can have on the lives of people with lung cancer, and advice for how people can talk to their doctor and find out more about it.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.